by admin | Feb 20, 2024 | News & Opinions
By Andrea Park -Fierce Biotech – For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first artificial...
by admin | Feb 16, 2024 | News & Opinions
by Technology Networks – Biopharma News – Initial trial suggests invariant natural killer cell therapy improves survival. Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with...
by admin | Feb 15, 2024 | News & Opinions
By Dr Naomi Phillips – Progress.org – Viral genetic material, integrated into our DNA millions of years ago, has an essential role in a key early stage in embryo development. Using a mouse model, scientists in Spain have shown that endogenous retroviruses,...
by admin | Feb 14, 2024 | News & Opinions
By Kyle LaHucik – Endpoints News Neurona Therapeutics has gathered $120 million in what is expected to be its last private financing round to wrap up an open-label study this year and move its epilepsy cell therapy into a randomized Phase II in 2025, CEO and...
by admin | Feb 13, 2024 | News & Opinions
by Marni Ellery – Berkley Engineering – Nobel laureate details new applications at Kuh Distinguished Lecture. Jennifer Doudna, Nobel laureate and Li Ka Shing Chancellor’s Chair and Professor in the Departments of Chemistry and of Molecular and Cell...
by admin | Feb 12, 2024 | News & Opinions
By Edvard Pettersson – Courthouse News Service – The FDA asked the Ninth Circuit to follow their colleagues on the 11th Circuit and find that novel stem cell procedures are not exempt from the agency’s oversight. PASADENA, Calif. (CN) — The U.S. Food...
